Filing Details

Accession Number:
0000930413-10-001074
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-02-26 12:00:00
Reporting Period:
2010-02-24
Filing Date:
2010-02-26
Accepted Time:
2010-02-26 16:39:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
727510 Enzon Pharmaceuticals Inc ENZN Biological Products, (No Disgnostic Substances) (2836) 222372868
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1201050 A Craig Tooman C/O Enzon Pharmaceuticals, Inc.
685 Route 202/206
Bridgewater, NJ 08807
Exec. Vp Finance, Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-02-24 50,000 $6.95 178,096 No 4 M Direct
Common Stock Acquisiton 2010-02-24 50,000 $5.73 228,096 No 4 M Direct
Common Stock Acquisiton 2010-02-24 50,000 $6.97 278,096 No 4 M Direct
Common Stock Disposition 2010-02-24 150,000 $9.27 128,096 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2010-02-24 50,000 $0.00 50,000 $6.95
Common Stock Stock Option (Right to Buy) Disposition 2010-02-24 50,000 $0.00 50,000 $5.73
Common Stock Stock Option (Right to Buy) Disposition 2010-02-24 50,000 $0.00 50,000 $6.97
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2005-06-20 2015-05-12 No 4 M Direct
0 2005-06-20 2015-06-10 No 4 M Direct
0 2009-11-23 2015-11-23 No 4 M Direct